Stock Groups

Lilly suspends Russia investments, will continue sale of essential drugs -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO – A pharmaceutical manufacturing facility of Eli Lilly and Company is shown at 50 ImClone Drive, Branchburg, New Jersey. This photo was taken March 5, 2021. REUTERS/Mike Segar

(Reuters) –U.S. drugmaker Eli Lilly and Co. said Tuesday that they would supply Russia with drugs for critical medical conditions, such as diabetes and cancer. However, the company will cease all investment and not start any new clinical research in Russia.

According to the company, promotional activities have been suspended and non-essential drugs are not being exported to Russia. The drug names were not provided.

Pfizer Inc (NYSE:), and Germany’s Bayer OTC: said Monday they would continue a humanitarian supply to Russia but will reduce spending elsewhere in Russia.

Lilly stated that any profits from Russia’s continued sales will go to charities dedicated to humanitarian aid.

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]